Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 May 15;156(10):743-5.
doi: 10.7326/0003-4819-156-10-201205150-00013.

Reactivation of hepatitis B during immunosuppressive therapy: potentially fatal yet preventable

Anna S F Lok  1 , John W Ward, Robert P Perrillo, Brian J McMahon, T Jake Liang
Affiliations

Reactivation of hepatitis B during immunosuppressive therapy: potentially fatal yet preventable

Anna S F Lok et al. Ann Intern Med. .
No abstract available

PubMed Disclaimer

References

    1. Hoofnagle JH. Reactivation of hepatitis B. Hepatology. 2009;49:S156–65. [PMID: 19399803] - PubMed
    1. Yeo W, Chan PK, Zhong S, Ho WM, Steinberg JL, Tam JS, et al. Frequency of hepatitis B virus reactivation in cancer patients undergoing cytotoxic chemo-therapy: a prospective study of 626 patients with identification of risk factors. J Med Virol. 2000;62:299–307. [PMID: 11055239] - PubMed
    1. Carroll MB, Forgione MA. Use of tumor necrosis factor alpha inhibitors in hepatitis B surface antigen-positive patients: a literature review and potential mechanisms of action. Clin Rheumatol. 2010;29:1021–9. [PMID: 20556450] - PubMed
    1. Chan TM, Fang GX, Tang CS, Cheng IK, Lai KN, Ho SK. Preemptive lamivudine therapy based on HBV DNA level in HBsAg-positive kidney allograft recipients. Hepatology. 2002;36:1246–52. [PMID: 12395336] - PubMed
    1. Evens AM, Jovanovic BD, Su YC, Raisch DW, Ganger D, Belknap SM, et al. Rituximab-associated hepatitis B virus (HBV) reactivation in lymphopro-liferative diseases: meta-analysis and examination of FDA safety reports. Ann Oncol. 2011;22:1170–80. [PMID: 21115603] - PMC - PubMed